These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3015036

  • 21. [Tumor selective drug delivery with lipid contrast medium (smancs/lipiodol): sustained antitumor effect, enhanced diagnostic value and quantification of dosage regimen].
    Maeda H, Konno T, Iwai K, Maki S, Tashiro S.
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):814-26. PubMed ID: 6326681
    [Abstract] [Full Text] [Related]

  • 22. Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma.
    Jinno K, Moriwaki S, Tanada M, Wada T, Mandai K, Okada Y.
    Cancer Chemother Pharmacol; 1992 Apr; 31 Suppl():S7-12. PubMed ID: 1333912
    [Abstract] [Full Text] [Related]

  • 23. Experience with intraarterial infusion of styrene maleic acid neocarzinostatin (SMANCS)-lipiodol in pancreatic cancer.
    Yoshida H, Onda M, Tajiri T, Uchida E, Arima Y, Mamada Y, Yamamoto K, Kaneko M, Terada Y, Kumazaki T.
    Hepatogastroenterology; 1999 Apr; 46(28):2612-5. PubMed ID: 10522050
    [Abstract] [Full Text] [Related]

  • 24. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I, Hirashima N.
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
    [Abstract] [Full Text] [Related]

  • 25. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
    Yoshikawa M, Ebara M, Fukuda H, Sugiura N, Saisho H.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
    [Abstract] [Full Text] [Related]

  • 26. Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
    Hirashima N, Sakakibara K, Itazu I, Hirai T, Nemoto A, Matsuura H, Kumada K, Nojiri O, Kano H.
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-91-S6-96. PubMed ID: 9151922
    [Abstract] [Full Text] [Related]

  • 27. Tumor-targeted chemotherapy with lipid contrast medium and macromolecular anticancer drug (SMANCS) for renal cell carcinoma.
    Kobayashi M, Imai K, Sugihara S, Maeda H, Konno T, Yamanaka H.
    Urology; 1991 Mar; 37(3):288-94. PubMed ID: 1848030
    [Abstract] [Full Text] [Related]

  • 28. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
    Inoue Y, Nakamura H.
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478
    [Abstract] [Full Text] [Related]

  • 29. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
    Konno T, Maeda H.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
    [Abstract] [Full Text] [Related]

  • 30. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma].
    Miura K, Nakao N, Yoshimoto A, Yamano T, Inoue J, Takayasu Y.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688
    [Abstract] [Full Text] [Related]

  • 31. [Subsegmental transcatheter hepatic arterial embolization under balloon occlusion of the corresponding hepatic vein with SMANCS].
    Shibata H, Sogabe M, Tsutsui A, Yokoi T, Morimoto M, Fukuda T, Hayashi S, Muguruma N, Ohkita Y, Okahisa T, Okamura S, Ito S.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():133-40. PubMed ID: 9512701
    [Abstract] [Full Text] [Related]

  • 32. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer].
    Ikeda K, Saitoh S, Kumada H.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682
    [Abstract] [Full Text] [Related]

  • 33. [Computed tomography after administration of SMANCS-lipiodol to liver cancers].
    Maki S, Konno T, Iwai K, Uchida M, Tashiro S, Miyauchi Y, Maeda H.
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug 20; 19(7):1443-9. PubMed ID: 6097616
    [No Abstract] [Full Text] [Related]

  • 34. [Treatment of hepatocellular carcinoma by segmental SMANCS Lipiodol-TAE].
    Hayashi T, Uchida H, Matsuo N, Sakaguchi H, Anai H, Tanaka T, Yamamoto T, Ooue S, Yoshioka T, Makutani S, Oishi H.
    Gan To Kagaku Ryoho; 1998 Feb 20; 25 Suppl 1():116-24. PubMed ID: 9512699
    [Abstract] [Full Text] [Related]

  • 35. [Tumor-targeted chemotherapy with lipid contrast medium and macro molecular anticancer agents theoretical considerations and clinical outcome].
    Maeda H, Konno T.
    Gan To Kagaku Ryoho; 1985 Mar 20; 12(3 Pt 2):773-82. PubMed ID: 2985005
    [Abstract] [Full Text] [Related]

  • 36. [Our initial experience with SMANCS in TAE for liver cancer].
    Fujita M, Inoue E, Kuroda C, Kasugai H, Sasaki Y, Nakano H, Imaoka S.
    Gan To Kagaku Ryoho; 1998 Feb 20; 25 Suppl 1():105-8. PubMed ID: 9512697
    [Abstract] [Full Text] [Related]

  • 37. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
    Hirashima N.
    Gan To Kagaku Ryoho; 1998 Feb 20; 25 Suppl 1():125-32. PubMed ID: 9512700
    [Abstract] [Full Text] [Related]

  • 38. [Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, smancs, for hepatocellular carcinoma].
    Konno T, Maeda H, Yokoyama I, Iwai K, Ogata K, Tashiro S, Uemura K, Mochinaga M, Watanabe E, Nakakuma K, Morinaga T, Miyauchi Y.
    Gan To Kagaku Ryoho; 1982 Nov 20; 9(11):2005-15. PubMed ID: 6307179
    [Abstract] [Full Text] [Related]

  • 39. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
    Konno T.
    Gan To Kagaku Ryoho; 1987 Feb 20; 14(2):373-80. PubMed ID: 3028275
    [Abstract] [Full Text] [Related]

  • 40. Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer--a pilot study.
    Ikeda K, Saitoh S, Suzuki Y, Tsubota A, Koida I, Kobayashi M, Arase Y, Chayama K, Murashima N, Kumada H.
    J Gastroenterol; 1997 Aug 20; 32(4):513-20. PubMed ID: 9250900
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.